Latest News - Abbott Laboratories
Top Corporates Hub
Abbott Laboratories
Does Libre 3 Plus Integration Expand Tandem’s Interoperability Edge And Bull Case For TNDM?
12.07.2026 01:07
In July 2026, Tandem Diabetes Care announced that its t:slim X2 insulin pump with Control-IQ+ technology is now compatible with Abbott’s FreeStyle Libre 3 Plus CGM in the UK, Switzerland, Sweden, Finland, and Italy, expanding CGM choice for pump users and enabling 15-day sensors with minute-by-minute glucose data. This integration strengthens Tandem’s ecosystem by pairing its advanced AutoBolus-enabled AID algorithm with one of Europe’s most widely used CGM platforms, potentially broadening...
DXCM Grew. The Stock Did Not. Someone Is Wrong
10.07.2026 12:08
The company’s business grew at a healthy clip, yet its stock price went sideways and its valuation fell. Something has to give.
Dividend Powerhouse: Abbott Laboratories (NYSE:ABT) Passes the Test for Sustainable Income
10.07.2026 10:20
Abbott Laboratories offers a reliable 2.64% dividend yield backed by strong profitability, a 10-year growth history, and a reasonable P/E ratio of 18.12, making it a solid passive income pick.
Advanced Therapeutics (Aging and Wellness) Market Report Now Available; 146-Page Study Profiling Abbott, Nestlé, Herbalife, Amway & 11 Others, Covering Sports, Functional & Therapeutic Nutrition
10.07.2026 08:02
The global advanced therapeutics market, focused on aging and wellness, is set to grow from $154.89 billion in 2024 to $275.35 billion by 2035, at a CAGR of 5.51%. This market, covering nutritional formulations and functional bioactives, is driven by aging populations, chronic conditions, and a shift toward preventive health. North America leads the market due to its robust healthcare ecosystem and consumer awareness. Key segments in the market include functional nutrition, energy and active agi
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
06.07.2026 13:00
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discover™ in Spain, Expanding Access to Tubeless Diabetes Technology
06.07.2026 11:00
ACTON, Mass., July 06, 2026--Insulet Accelerates Global Growth with Launch of Omnipod 5 and Omnipod Discover in Spain, Expanding Access to Tubeless Diabetes Technology
Abbott Laboratories (NYSE:ABT) Passes the Caviar Cruise Quality Screen with Strong Growth and Profitability
03.07.2026 12:00
Quality investing strategy screening Abbott Laboratories for durable growth, high ROIC of 20.57%, strong cash flow, and sound fundamentals as a potential long-term holding.
What Could Push BSX Stock Higher From Here?
02.07.2026 17:38
While a guidance cut has reset expectations, several core Boston Scientific franchises are accelerating. The Neuromodulation and Interventional Oncology businesses both posted organic sales growth of 15% last quarter. This internal momentum in high-value categories contrasts sharply with the new, more cautious company-wide outlook.
Baird Initiates Coverage of Abbott Laboratories (ABT) with Outperform Recommendation
02.07.2026 17:08
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets
01.07.2026 12:30
SAN DIEGO, July 01, 2026--The t:slim X2™ insulin pump from Tandem Diabetes Care is now compatible with Abbott’s FreeStyle Libre 3 Plus CGM sensor in five EU countries.
Here Are Wednesday’s Best Wall Street Analyst Research Calls: Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesforce, ServiceNow,SpaceX, and More
01.07.2026 12:03
Pre-Market Stock Futures: Futures are trading lower as we get ready to start the third quarter after a record-setting second quarter that saw the Dow Jones Industrial Average close at 52,317, up 0.26% to finish the venerable index’s best first half since 2021, while the Nasdaq finished the session at 26,213, up 1.52% for the ... Here Are Wednesday’s Best Wall Street Analyst Research Calls: Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesforce, ServiceNow,SpaceX,
US criminal probe into Abbott infant-formula plant closed
30.06.2026 13:57
Abbott Laboratories has reached a proposed settlement that will see civil penalties paid under the US False Claims Act.
Abbott Laboratories (ABT) Stock After Recent Rebound Is There Still Value Left
27.06.2026 07:08
How Abbott Laboratories Stock Has Been Performing Abbott Laboratories has attracted fresh attention from investors after a recent rebound in its share price, raising the question of whether the current level reflects fair value or an opportunity. Over the past week the stock gained 6.5%, with a 9.9% rise over the last 30 days, although returns since the start of the year are down 24.2% and the one year return is down 28.5%. This gives important context to the recent strength. These moves have...
Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?
26.06.2026 12:35
DXCM outpaces Abbott with expanding CGM access, new product launches and broader coverage, making it the stronger stock to watch now.
How Does Wall Street View Abbott Laboratories (ABT)’s Outlook?
25.06.2026 06:21
Backed by bullish positioning from 73 hedge funds and analyst expectations of 30.93% upside, Abbott Laboratories (NYSE:ABT) ranks among the top stocks to buy for financial stability. Abbott Laboratories (NYSE:ABT) has drawn mixed analyst signals recently, with one firm seeing hidden value in a breakup scenario while another trimmed its outlook on broader sector concerns. […]
Jim Cramer on Boston Scientific: “This Whole Cohort Is Just Too Hard to Own”
23.06.2026 14:41
Boston Scientific Corporation (NYSE:BSX) was among the stocks Jim Cramer discussed as he said that the Iran peace negotiations could trigger an oil glut, cool inflation, and pull interest rates down. A caller asked about Cramer’s thoughts on the stock, and he replied: Now, I gotta tell you something, I was shocked at the decline […]
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
23.06.2026 13:00
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Abbott (ABT) Launches Similac Campaign To Ease Social Media Pressure On Young Parents
23.06.2026 09:07
Similac, Abbott Laboratories' (NYSE:ABT) infant nutrition brand, has launched its "Love Without Measure" initiative. The campaign focuses on easing social media pressures on young and Gen Z parents and promoting a more supportive online community. Similac is partnering with motherhood experts and social media influencers to highlight mental health, inclusivity, and judgment free parenting. For investors following Abbott Laboratories, the move highlights how the company is engaging with...
Citi Believes Abbott (ABT) Shares are Undervalued Relative to Business Segments
19.06.2026 03:37
Abbott Laboratories (NYSE:ABT) is included among the Dividend Stock Portfolio: Top 10 Stocks to Buy According to Reddit. On June 17, Citi reiterated its Buy rating on Abbott Laboratories (NYSE:ABT). It said that the company’s individual businesses may be worth more than the market currently values the company as a whole. According to the firm’s […]
FiberSense plans CGM’s commercial readiness following CE mark
18.06.2026 16:03
FiberSense’s device uses optical sensor technology to monitor the concentration of glucose in the subcutaneous tissue fluid.